×
Reboxetine, a Unique Selective NRI, Prevents Relapse and Recurrence in Long-Term Treatment of Major Depressive Disorder PDF
$ 40.00
Reboxetine, a Unique Selective NRI, Prevents Relapse and Recurrence in Long-Term Treatment of Major Depressive Disorder PDF quantity
$ 40.00
×
Efficacy of Venlafaxine Extended Release in Patients With Major Depressive Disorder and Comorbid Generalized Anxiety Disorder PDF
$ 40.00
Efficacy of Venlafaxine Extended Release in Patients With Major Depressive Disorder and Comorbid Generalized Anxiety Disorder PDF quantity
$ 40.00
×
Chromium Potentiation of Antidepressant Pharmacotherapy for Dysthymic Disorder in 5 Patients PDF
$ 40.00
Chromium Potentiation of Antidepressant Pharmacotherapy for Dysthymic Disorder in 5 Patients PDF quantity
$ 40.00
×
Treatment Failure With a Tricyclic Antidepressant Followed by Lithium Addition and Response to Subsequent Electroconvulsive Therapy PDF
$ 40.00
Treatment Failure With a Tricyclic Antidepressant Followed by Lithium Addition and Response to Subsequent Electroconvulsive Therapy PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
